Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2017 April;108(2) > Minerva Medica 2017 April;108(2):197-8

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

LETTERS TO THE EDITOR  


Minerva Medica 2017 April;108(2):197-8

DOI: 10.23736/S0026-4806.17.04857-1

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Prognostic value of lncRNA HULC in patients with solid tumors

Wei SONG, Run-Jin ZHANG, Shu-Bing ZOU, Kai WANG

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang, University, Nanchang, China


PDF  


top of page

Publication History

Issue published online: February 20, 2017
Manuscript accepted: January 5, 2017
Manuscript revised: December 12, 2016
Manuscript received: October 6, 2016

Cite this article as

Song W, Zhang RJ, Zou SB, Wang K. Prognostic value of lncRNA HULC in patients with solid tumors. Minerva Med 2017;108:197-8. DOI: 10.23736/S0026-4806.17.04857-1

Corresponding author e-mail

zousb999@163.com